Valuation Dermapharm Holding SE

Stocks

Market Closed - Xetra 11:35:12 2026-10-23 EDT			5-day change	1st Jan Change
38.40 ^EUR	-0.78%		+1.45%	-2.41%

09-03	Dermapharm Holding SE : Jefferies remains Neutral	ZD
08-27	Dermapharm Holding SE : Receives a Buy rating from Berenberg	ZD

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,808	2,020	2,280	2,094	2,119	1,902	-	-
Change	-	-57.98%	12.85%	-8.12%	1.16%	-10.21%	-	-
Enterprise Value (EV) ¹	5,206	2,388	3,216	2,964	2,974	2,714	2,589	2,480
Change	-	-54.13%	34.69%	-7.85%	0.33%	-8.73%	-4.6%	-4.23%
P/E	23x	15.1x	36.5x	18.4x	16x	14.6x	12.9x	11.6x
PBR	9.67x	3.8x	4.23x	3.47x	3.05x	2.86x	2.5x	2.19x
PEG	-	-0.4x	-0.7x	0.2x	1x	2.21x	1x	1x
Capitalization / Revenue	5.1x	1.97x	2.01x	1.77x	1.82x	1.57x	1.52x	1.46x
EV / Revenue	5.52x	2.33x	2.83x	2.51x	2.55x	2.25x	2.06x	1.91x
EV / EBITDA	14.8x	6.64x	10.4x	9.39x	9.16x	7.96x	7.15x	6.5x
EV / EBIT	17.4x	9.8x	17.6x	13.7x	13.5x	10.9x	9.69x	8.67x
EV / FCF	27.5x	9.57x	18.1x	18.2x	15.9x	17.7x	14.9x	13.3x
FCF Yield	3.63%	10.4%	5.53%	5.5%	6.29%	5.65%	6.7%	7.53%
Dividend per Share ²	2.17	1.05	0.88	0.9	0.88	1.02	1.139	1.217
Rate of return	2.43%	2.8%	2.08%	2.31%	2.24%	2.66%	2.97%	3.17%
EPS ²	3.89	2.49	1.16	2.11	2.46	2.623	2.967	3.296
Distribution rate	55.8%	42.2%	75.9%	42.7%	35.8%	38.9%	38.4%	36.9%
Net sales ¹	942.9	1,025	1,135	1,181	1,165	1,209	1,254	1,299
EBITDA ¹	351.1	359.8	310.2	315.6	324.8	340.9	362	381.2
EBIT ¹	298.5	243.7	182.9	216.9	220.7	249.3	267.3	286
Net income ¹	209.6	134.2	62.37	113.8	132.4	137.3	155.3	171.7
Net Debt ¹	398.1	367.8	936.6	869.4	855.1	811.7	686.9	577.5
Reference price ²	89.30	37.52	42.34	38.90	39.35	38.40	38.40	38.40
Nbr of stocks (in thousands)	53,840	53,840	53,840	53,840	53,840	49,541	-	-
Announcement Date	4/12/22	3/28/23	3/28/24	3/27/25	3/30/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
DERMAPHARM HOLDING SE	14.64x	2.25x	7.96x	2.66%	2.13B
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.5x	18.29x	2.02%	636B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.67x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	27.98x	6.56x	17.62x	2.17%	400.65B
Weighted average by Cap.	35.13x	8.29x	20.39x	1.8%